CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 46,047	$ (249,064)
Adjustments to net income (loss):
Depreciation and amortization	484,066	496,231
Deferred income tax expense (benefit)	16,407	4,712
Impairments and other charges	5,318
Amortization of debt discount and deferred financing costs	6,393	8,012
Losses (gains) on debt buyback	(25,202)	(1,636)
Losses (gains) on long-lived assets, net	7,980	1,130
Losses (gains) on investments, net	(1,089)	544
Share-based compensation	12,671	11,854
Foreign currency transaction losses (gains), net	21,725	(4,054)
Mark-to-market (gain) loss on warrants	(44,314)	59,717
Noncontrolling interest	(41,128)	(32,132)
Other	144	176
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(1,890)	(29,828)
Inventory	(18,305)	(312)
Other current assets	12,140	(12,578)
Other long-term assets	(786)	(12,301)
Trade accounts payable and accrued liabilities	(63,389)	30,538
Income taxes payable	(5,892)	(66)
Other long-term liabilities	45,045	30,157
Net cash provided by (used for) operating activities	455,941	301,100
Cash flows from investing activities:
Purchases of investments	(28,083)	(19,000)
Capital expenditures	(406,695)	(272,080)
Proceeds from sales of assets	9,677	24,030
Other	(3,873)	48
Net cash (used for) provided by investing activities	(428,974)	(267,002)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	250,000
Reduction in long-term debt	(296,547)	(133,853)
Debt issuance costs	(8,036)	(3,864)
Proceeds from revolving credit facilities	220,000	250,000
Reduction in revolving credit facilities	(220,000)	(710,000)
Proceeds from issuance of common shares, net of issuance costs		3,767
Payments for employee taxes on net settlement of equity awards	(7,079)	(4,523)
Dividends to common and preferred shareholders	(194)	(65)
Distributions to noncontrolling interest	(2,269)	(3,489)
Distribution of trust account for special purpose acquisition company	(186,933)
Sale of non-controlling interest - special purpose acquisition company	305,000
Other	274	(445)
Net cash (used for) provided by financing activities	54,216	(602,472)
Effect of exchange rate changes on cash and cash equivalents	(10,773)	(863)
Net increase (decrease) in cash and cash equivalents and restricted cash	70,410	(569,237)
Cash and cash equivalents and restricted cash, beginning of period	737,140	1,273,510
Cash and cash equivalents and restricted cash, end of period	807,550	704,273
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	451,025	991,471
Restricted cash, beginning of period	286,115	282,039
Cash and cash equivalents and restricted cash, beginning of period	737,140	1,273,510
Cash and cash equivalents, end of period	387,483	420,307
Restricted cash, end of period	$ 420,067	$ 283,966
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 807,550	$ 704,273